Media must start providing quality

first_imgCategories: Letters to the Editor, OpinionWelcome Rosanne Cheeseman, The Gazette’s newest board member. Your article states that Cheeseman believes it will be critical for newspapers to “continue providing quality content and “maintaining” the trust of the community.If she is to make any difference at all to the sad state of journalism nowadays, may I suggest that she rephrase her statement to read: It will be critical for newspapers to “start’ providing quality content and “regain” the trust of the community.Case in point, five pages later you printed a story about the U.S. military giving a pass to Afghan pedophiles, as if this was some shocking new story. In fact, homosexual pedophilia on the part of Afghan soldiers has been a well-known peculiarity of the Afghan war for at least 10 years now, dating back to the Bush administration. Heterosexual pedophilia is even more rampant, though no one would know it from reading The Gazette. President Trump’s “escalating” war on the media is refreshing and well-justified.As another example, I urge all readers to log into YouTube and search for “Womens March.” Read the signs and watch the behavior of the marchers, which is clearly deranged and dysfunctional to say the least. Then compare what you see with your own eyes to the nonsensical, fake coverage of this event which you will find in The Sunday Gazette.Mike BlyskalBallston SpaMore from The Daily Gazette:EDITORIAL: Find a way to get family members into nursing homesEDITORIAL: Thruway tax unfair to working motoristsEDITORIAL: Beware of voter intimidationEDITORIAL: Urgent: Today is the last day to complete the censusGuilderland girls’ soccer team hands BH-BL first league losslast_img read more

Planning

first_imgWould you like to read more?Register for free to finish this article.Sign up now for the following benefits:Four FREE articles of your choice per monthBreaking news, comment and analysis from industry experts as it happensChoose from our portfolio of email newsletters To access this article REGISTER NOWWould you like print copies, app and digital replica access too? SUBSCRIBE for as little as £5 per week.last_img

Planning

first_imgWould you like to read more?Register for free to finish this article.Sign up now for the following benefits:Four FREE articles of your choice per monthBreaking news, comment and analysis from industry experts as it happensChoose from our portfolio of email newsletters To access this article REGISTER NOWWould you like print copies, app and digital replica access too? SUBSCRIBE for as little as £5 per week.last_img

Internet firm snaps up West End HQ

first_imgWould you like to read more?Register for free to finish this article.Sign up now for the following benefits:Four FREE articles of your choice per monthBreaking news, comment and analysis from industry experts as it happensChoose from our portfolio of email newsletters To access this article REGISTER NOWWould you like print copies, app and digital replica access too? SUBSCRIBE for as little as £5 per week.last_img

Heron opts for leisure sell-off

first_imgTo access this article REGISTER NOWWould you like print copies, app and digital replica access too? SUBSCRIBE for as little as £5 per week. Would you like to read more?Register for free to finish this article.Sign up now for the following benefits:Four FREE articles of your choice per monthBreaking news, comment and analysis from industry experts as it happensChoose from our portfolio of email newsletterslast_img

Reading between the lines

first_imgWould you like to read more?Register for free to finish this article.Sign up now for the following benefits:Four FREE articles of your choice per monthBreaking news, comment and analysis from industry experts as it happensChoose from our portfolio of email newsletters To access this article REGISTER NOWWould you like print copies, app and digital replica access too? SUBSCRIBE for as little as £5 per week.last_img

Living for the City

first_imgTo access this article REGISTER NOWWould you like print copies, app and digital replica access too? SUBSCRIBE for as little as £5 per week. Would you like to read more?Register for free to finish this article.Sign up now for the following benefits:Four FREE articles of your choice per monthBreaking news, comment and analysis from industry experts as it happensChoose from our portfolio of email newsletterslast_img

PREMIUMThree Indonesian crew on Japan-moored cruise ship test positive for coronavirus

first_imgTopics : LOG INDon’t have an account? Register here Linkedin Google Forgot Password ? Foreign Minister Retno Marsudi demanded on Tuesday assurances from the Japanese authorities after it emerged that at least three Indonesian crew members of the Diamond Princess cruise ship in Japan’s Tokyo Bay had tested positive for the novel coronavirus that causes COVID-19.The ship initially had 3,711 people on board when it was placed under mandatory quarantine at a port in Yokohama, Japan, last week over fears of contamination from a passenger who disembarked in Hong Kong last month and who had contracted the virus. Among those on board were 78 Indonesian nationals who worked as part of the ship’s crew and all of whom had a clean bill of health up until Tuesday.Japan has come under fire for its handling of the situation after the number of confirmed cases rose almost daily among passengers and crew members on board the ship. Japan confirmed on Tuesday tha… Indonesia Japan health virus COVID-19 cruise quarantine Facebook Log in with your social accountlast_img read more

PREMIUMPolice hunt radioactive waste dumper in Banten

first_imgLinkedin Facebook The Nuclear Energy Regulatory Agency (Bapeten) is working with the police to investigate the origins of the radioactive Caesium-137 waste found in the Batan Indah housing complex in South Tangerang, Banten, recently.Bapeten manages around 14,000 permits for nuclear use across the country.“We have the data of which industries use Caesium-137 but we don’t have the capacity to investigate how the materials ended up in that neighborhood. That’s why we are working with the police,” Bapeten head Jazi Eko Istiyanto said on Tuesday.The Jakarta Police, the South Tangerang Police, the National Police’s forensics unit and criminal investigation department (Bareskrim) are currently probing the case.“We examined the scene on Sunday. Bareskrim collected samples from the scene to be further analyzed,” National Police spokesperson Sr. Comr. Asep … Forgot Password ? Topics : Log in with your social account Google LOG INDon’t have an account? Register here BATAN waste radioactive South-Tangerang #Police police radioactive-waste #radioactive-waste #BATANlast_img read more

Fujifilm shares jump 15% on China coronavirus drug trial boost

first_imgBut a Fujifilm spokesman said the company expects no direct earnings impact from potential sales growth of Favipiravir in China, at least for now, as its license for the key ingredient in the country already expired last year.In Japan, Fujifilm manufactures Avigan only on receiving orders from the government and has no sales target for the drug, she said.Fujifilm shares closed Wednesday up 15.4% at their daily limit high of 5,238 yen.Fujifilm’s company logo (top) is seen at its exhibition hall nearby the headquarters of Fujifilm Holdings Corp in Tokyo, Japan June 12, 2017. (REUTERS/Kim Kyung-Hoon) Shares in Japan’s Fujifilm Holdings Corp surged 15% on Wednesday after a Chinese official said an active ingredient of the company’s Avigan anti-flu drug appeared to help coronavirus patients recover.Avigan, also known as Favipiravir, is manufactured by a subsidiary of Fujifilm, which has a healthcare arm although it is better known for its cameras. The drug was approved for use in Japan in 2014.Favipiravir has been effective, with no obvious side-effects, in helping coronavirus patients recover, Zhang Xinmin, an official at China’s Science and Technology Ministry, told reporters at a news conference on Tuesday. Topics :center_img In a clinical trial in Shenzhen involving 80 participants, patients who took Favipiravir showed greater chest improvement and took less time to test negative for the genomic trace of the virus, compared with patients not given the drug, Zhang said.First developed by Fujifilm Toyama Chemical Co Ltd, the drug has been approved for manufacturing in China by Zhejiang Hisun Pharmaceutical Co Ltd for use against new or recurring influenza in adults, the Chinese drugmaker said in a filing last month.In 2016, the Japanese government supplied Favipiravir as an emergency aid to counter the Ebola virus outbreak in Guinea. last_img read more